Omeros Corporation today announced two presentations that will be featured at the 2025 Tandem Meetings ? the Transplantation & Cellular Therapy Meetings of the American Society for Transplantation and ...

The poster titled “ Preclinical and Translational Pharmacokinetics of GD2-SADA, a Self-Assembling and Disassembling (SADA) Bispecific Fusion Protein for Pretargeted Radioimmunotherapy (PRIT)” ...

Zevra to receive a 2025 New Treatment Award for MIPLYFFA™ at the 21st Annual WORLDSymposiumEight abstracts discussing data and clinical ...

The data analysis is being finalized, and we remain on track to report topline results in early February.” “During the quarter, we delivered numerous posters, presentations ... by Paula Trujillo Diaz, ...

BJP returns to power after gap of 27 yrs, ending AAP's reign. Congress draws a blank for 3rd consecutive assembly poll.

THB335 Phase 1 data support advancement into Phase 2 clinical trial in chronic spontaneous urticaria (CSU)Company initiating process to leverage ...

Blueprint Medicines Corporation ( NASDAQ: BPMC) Q4 2024 Earnings Conference Call February 13, 2025 8:00 AM ET ...

Agenus Inc. , a leader in immuno-oncology, today announced that BOT/BAL will be featured in two presentations at the upcoming American Association for Cancer Research (AACR) IO Annual Meeting that ...

The Vietnam digital printing market has witnessed significant growth in recent years, driven by various factors such as technological advancements, increasing demand for short-run printing, and the ...

(AML) patients across both original and expansion cohorts remain in complete remission (CR), with a median follow-up of 20.1 months AML patients treated demonstrated one-year ...

From the pianoforte to the smartphone, each wave of tech has sparked fears of brain rot. But the problem isn’t our ability to ...

Hoth Therapeutics, Inc. (NASDAQ: HOTH), a biopharmaceutical company dedicated to developing innovative therapies for unmet medical needs, today announced its collaboration with OnTargetx R&D Inc. to ...